Development of Cure for Coronavirus from Survivors’ Blood to Take 30 Days

| By | Drug Development

Scientists from Russian Academy of Sciences’ Institute of Chemical Biology and Fundamental Medicine are ready to develop a coronavirus cure, based on coronavirus survivors’ blood, in 30 days, the Institute press service said.

“The experimental medicine for specific coronavirus infection therapy will be an enriched fraction of human blood antiviral immunoglobulins, extracted from plasma of patients who recovered from the coronavirus. Its development is expected to take 30 days,” the press service said.

According to the press service, some 500 ml of coronavirus survivor’s blood plasma is needed to make a cure. The medicine is expected to be administered intravenously. The scientists believe that this medicine will be completely sterile and non-pyrogenic. To develop the medicine, the scientists need 6 million rubles ($76,482) in funding.

GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.